Corrigendum

Nicolas D. Iadarola et al. (2015) Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review. Ther Adv Chronic Dis 6(3) 97-114. In the legend of Figure 1 (two colours were reversed). The figure is correct but the legend is incorrect and has been corrected below: (Black circles: glutamate; grey circles: glutamine; blue circles: BDNF; blue channel: NMDA receptor complex; maroon channel: AMPA receptor complex; red channel: glial transporter-1/excitatory amino acid transporter 2 (GLT-1/EAAT2); olive channel: system xC-; peach channel: vesicular glutamate transporter; maroon seven-transmembrane receptor: metabotropic glutamate receptor type 2/3; olive seven-transmembrane receptor: metabotropic glutamate receptor type 1/5; grey dimeric receptor: TrkB receptor. Akt, Ak thymoma/protein kinase B; AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; eEF2, eukaryotic elongation factor 2; ERK, extracellular signal-regulated kinase; GABA, -aminobutyric acid; mTOR, mammalian target of rapamycin; NMDA, N-methyl-D-aspartate; SNARE, soluble NSF attachment protein receptor (superfamily); TrkB, tropomyosin-related kinase B.
Source: Therapeutic Advances in Chronic Disease - Category: Internal Medicine Tags: Corrigendum Source Type: research